rct
    2021
    High Quality

    Nattokinase atherothrombotic prevention study: a randomized controlled trial

    Hodis HN, Mack WJ, Meiselman HJ

    Published in Clinical Hemorheology and Microcirculation

    Key Findings

    Nattokinase did not change carotid intima-media thickness progression or fibrinolytic and coagulation markers versus placebo over one year.

    Conclusions

    Rigorous null result against the atherosclerosis claims.

    Limitations

    Single centre, one-year follow-up.

    Supplements Studied

    Nattokinase did not change carotid intima-media thickness progression or coagulation markers versus placebo over one year.

    Related Health Concerns

    Elevated Blood Pressure

    Study Details

    Year:2021
    Sample Size:265
    Duration:52 weeks
    Quality Score:8/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.